Abstract
D ipyridamole-thallium imaging is routinely used in clinical practice to detect coronary artery disease in patients unable to exercise. Major side effects such as prolonged ischemia or symptomatic hypotension are uncommon and respond rapidly to administration of intravenous aminophylline [1]. Catastrophic events such as myocardial infarction or cardiac arrest have been reported but are not common [2,3]. We describe a unique case of myocardial stunning (defined as prolonged but reversible post-ischemic regional ventricular dysfunction [4]) and acute pulmonary edema during dipyridamole-thallium imaging.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
